• Plant-based low-carbohydrate diets improve weight, lipids, and glycemic control • Metabolic benefits are comparable or superior to omnivorous low-carb diets • Adherence is higher in moderate plant-based low-carbohydrate interventions • Evidence supports short-term efficacy of plant-based ketogenic diets • Sustainability data are limited and mostly indirect in current trials Plant-based adaptations of low-carbohydrate (PB-LCD) and ketogenic diets (PB-KD) have emerged as nutritional models aiming to combine metabolic efficacy, nutritional adequacy, and environmental sustainability within a One Health framework. These regimens may align human and planetary health goals, especially in long-term therapeutic contexts such as GLUT1 deficiency or drug-resistant migraine, where ketogenic approaches are established. However, evidence on the integration of plant-based principles into carbohydrate-restricted diets remains limited, particularly regarding sustainability and long-term feasibility. To critically assess the effects of PB-LCD and PB-KD on metabolic outcomes, adherence, and sustainability indicators in adults with overweight, obesity, or metabolic disorders. A systematic search of PubMed/MEDLINE, Embase, Cochrane Library, Web of Science, and Google Scholar (January 2000–March 2025) identified randomized controlled trials testing predominantly plant-based low-carbohydrate diets. Methodological quality was assessed with the Cochrane RoB 2 tool, and evidence certainty was graded using GRADE. Primary outcomes were body composition, glycemic and lipid profiles; secondary outcomes included adherence and sustainability measures. Seven RCTs (n = 976; duration 4–52 weeks) were included. Both PB-LCD and PB-KD significantly reduced body weight (−5 to −7 kg), LDL-cholesterol, and HbA1c, with effects comparable or superior to control diets. GRADE certainty was moderate for weight and lipid parameters and moderate-to-low for glycemic control. Adherence was high in controlled settings but declined in free-living conditions. PB-LCDs showed better long-term feasibility, whereas PB-KDs induced stronger short-term effects but required supervision. Only one study quantified greenhouse gas emissions (−0.63 kg CO₂/day). Sustainability evidence was very low. PB-LCDs and PB-KDs are clinically effective, nutritionally safe, and potentially sustainable models for metabolic improvement, though long-term integrative trials are needed.
Mazzola et al. (Sun,) studied this question.